Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
4.12
0.01 (0.24%)
At close: Aug 15, 2025, 12:51 PM
Aquestive Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -65.04M | -54.24M | -44.14M | -35.19M | -25.72M | -28.77M | -7.87M | -12.11M | -22.61M | -33.12M | -54.41M | -71M | -73.02M | -69.09M | -70.54M | -61.96M | -63.96M | -53.92M |
Depreciation & Amortization | 585K | 650K | 718K | 1.04M | 1.14M | 1.23M | 1.34M | 1.27M | 1.61M | 1.99M | 2.39M | 2.72M | 2.86M | 2.94M | 2.96M | 3.34M | 3.26M | 3.31M |
Stock-Based Compensation | 7.45M | 7.11M | 7.1M | 5.64M | 4.83M | 3.92M | 2.69M | 2.46M | 2.22M | 3.81M | 4.38M | 5.36M | 6.72M | 6.22M | 6.82M | 6.66M | 6.18M | 6.23M |
Other Working Capital | -7.43M | -15.89M | -15.79M | -15.58M | -13.16M | -5.39M | -1.67M | 23.11M | 28.16M | 33.47M | 27.99M | 3.46M | 1.24M | -1.52M | 3.56M | 3.67M | 8.04M | -4.54M |
Other Non-Cash Items | 11.86M | 10.61M | 10.52M | 13.18M | 10.54M | 8.23M | 5.33M | -118K | 2.02M | 3.87M | 5.85M | 7.77M | 10.36M | 12.81M | 15.69M | 16.73M | 12.68M | 8.93M |
Deferred Income Tax | n/a | n/a | n/a | -2.53M | -2.53M | -2.53M | -2.53M | n/a | n/a | n/a | n/a | 13.82M | 13.82M | 13.82M | 13.82M | n/a | n/a | n/a |
Change in Working Capital | -4.54M | -12.9M | -9.96M | -16.34M | -12.95M | -7.67M | -5.34M | 15.5M | 28.92M | 36.97M | 32.01M | 15.03M | 1.08M | -68K | -1.73M | -3.2M | 4.16M | -10.46M |
Operating Cash Flow | -49.68M | -48.77M | -35.76M | -34.21M | -24.68M | -25.58M | -6.38M | 7.01M | 12.16M | 13.51M | -9.79M | -26.3M | -38.17M | -33.36M | -32.98M | -38.43M | -37.68M | -45.92M |
Capital Expenditures | -337K | -265K | -159K | -160K | -231K | -1.02M | -995K | -1M | -2.57M | -2.42M | -2.52M | -3.03M | -1.4M | -914K | -913K | -616K | -571K | -489K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.52M | -4.02M | -4.02M | -4.02M | -2.03M | -533K | -533K | -533K | -236K | -236K | -236K |
Investing Cash Flow | -337K | -265K | -159K | -160K | -231K | -1.02M | -995K | -1M | -2.57M | -2.42M | -2.52M | -3.03M | -1.4M | -914K | -913K | -616K | -571K | -489K |
Debt Repayment | -24K | -29K | -23K | -39M | -37.97M | -41.42M | -50.5M | -12.2M | -13.22M | -9.76M | -675K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3K | -10K | -62K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 83.14M | 83.27M | 83.61M | 38.73M | 42.7M | 46.24M | 45.56M | 453K | -4M | -2.35M | -1.32M | 4.8M | 5.47M | 329K | 329K | 28.55M | 28.56M | 28.49M |
Financial Cash Flow | 20.69M | 22.5M | 83.59M | 87.35M | 92.34M | 94.92M | 3.97M | 265K | -4.85M | 1.06M | 11.56M | 16.81M | 23.03M | 21.52M | 30.11M | 53.15M | 47.06M | 38.38M |
Net Cash Flow | -29.33M | -26.54M | 47.67M | 52.98M | 67.43M | 68.32M | -3.4M | 6.27M | 4.74M | 12.15M | -751K | -12.52M | -16.54M | -12.76M | -3.78M | 14.1M | 8.81M | -8.02M |
Free Cash Flow | -50.02M | -49.04M | -35.92M | -34.37M | -24.91M | -26.6M | -7.38M | 6M | 9.59M | 11.09M | -12.31M | -29.33M | -39.57M | -34.28M | -33.89M | -39.05M | -38.25M | -46.41M |